Hyperlipoproteinemia epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 6: | Line 6: | ||
Hyperlipidemia is a common health problem that tends to more often affect the elderly population in developed countries. It is a major cause of disease burden globally as a risk factor for cardiovascular and cerebrovascular diseases.<ref name="urlWHO | Raised cholesterol">{{cite web |url=http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/index.html |title=WHO | Raised cholesterol |format= |work= |accessdate=2012-10-26}}</ref> | Hyperlipidemia is a common health problem that tends to more often affect the elderly population in developed countries. It is a major cause of disease burden globally as a risk factor for cardiovascular and cerebrovascular diseases.<ref name="urlWHO | Raised cholesterol">{{cite web |url=http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/index.html |title=WHO | Raised cholesterol |format= |work= |accessdate=2012-10-26}}</ref> | ||
==Prevalence== | ==Epidemiology and Demographics== | ||
===Prevalence=== | |||
Worldwide, the [[prevalence]] of hyperlipidemia is about 39,000 per 100,000 patients. | Worldwide, the [[prevalence]] of hyperlipidemia is about 39,000 per 100,000 patients. | ||
In developed countries, the [[prevalence]] of hyperlipidemia is about 51,000 per 100,000 patients. | In developed countries, the [[prevalence]] of hyperlipidemia is about 51,000 per 100,000 patients. | ||
In developing countries, the [[prevalence]] of hyperlipidemia is about 26,000 per 100,000 patients. | In developing countries, the [[prevalence]] of hyperlipidemia is about 26,000 per 100,000 patients. | ||
==Age== | ===Age=== | ||
The [[prevalence]] of hyperlipidemia increases with age. It may be present in children and young adults but is seen more frequently in later life. | The [[prevalence]] of hyperlipidemia increases with age. It may be present in children and young adults but is seen more frequently in later life. | ||
==Gender== | ===Gender=== | ||
The [[prevalence]] of hyperlipidemia among men is about 37,000 per 100,000, and among women is about 40,000 per 100,000. Thus gender is not much associated with an increased risk of hyperlipidemia. However, hyperlipidemia is more common in men younger than 55 years and in women older than 55 years. | The [[prevalence]] of hyperlipidemia among men is about 37,000 per 100,000, and among women is about 40,000 per 100,000. Thus gender is not much associated with an increased risk of hyperlipidemia. However, hyperlipidemia is more common in men younger than 55 years and in women older than 55 years. | ||
==Developed Countries== | ===Developed Countries=== | ||
People in the developed countries have a higher prevalance of hyperlipidemia. The prevalence also increases noticeably according to the income level of the country. In high-income countries, over 50% of adults have raised [[total cholesterol]]; more than double the level of the low-income countries. | People in the developed countries have a higher prevalance of hyperlipidemia. The prevalence also increases noticeably according to the income level of the country. In high-income countries, over 50% of adults have raised [[total cholesterol]]; more than double the level of the low-income countries. | ||
==Developing Countries== | ===Developing Countries=== | ||
In the past, the incidence and prevalence of hyperlipidemia were low in developing countries in comparison to developed countries. But with the westernization of developing regions in Middle East, India, and Central and South America, the incidence of hyperlipidemia is increasing. | In the past, the incidence and prevalence of hyperlipidemia were low in developing countries in comparison to developed countries. But with the westernization of developing regions in Middle East, India, and Central and South America, the incidence of hyperlipidemia is increasing. | ||
| Line 31: | Line 32: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Metabolic disorders]] | [[Category:Metabolic disorders]] | ||
{{WH}} | |||
{{WS}} | |||
Revision as of 21:11, 13 February 2013
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hardik Patel, M.D.
Overview
Hyperlipidemia is a common health problem that tends to more often affect the elderly population in developed countries. It is a major cause of disease burden globally as a risk factor for cardiovascular and cerebrovascular diseases.[1]
Epidemiology and Demographics
Prevalence
Worldwide, the prevalence of hyperlipidemia is about 39,000 per 100,000 patients. In developed countries, the prevalence of hyperlipidemia is about 51,000 per 100,000 patients. In developing countries, the prevalence of hyperlipidemia is about 26,000 per 100,000 patients.
Age
The prevalence of hyperlipidemia increases with age. It may be present in children and young adults but is seen more frequently in later life.
Gender
The prevalence of hyperlipidemia among men is about 37,000 per 100,000, and among women is about 40,000 per 100,000. Thus gender is not much associated with an increased risk of hyperlipidemia. However, hyperlipidemia is more common in men younger than 55 years and in women older than 55 years.
Developed Countries
People in the developed countries have a higher prevalance of hyperlipidemia. The prevalence also increases noticeably according to the income level of the country. In high-income countries, over 50% of adults have raised total cholesterol; more than double the level of the low-income countries.
Developing Countries
In the past, the incidence and prevalence of hyperlipidemia were low in developing countries in comparison to developed countries. But with the westernization of developing regions in Middle East, India, and Central and South America, the incidence of hyperlipidemia is increasing.
References
- ↑ "WHO | Raised cholesterol". Retrieved 2012-10-26.